Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:52:12.338Z.
Calculation as of: 2026-10-06T18:52:12.338Z.
Quote observation: 2026-10-06T18:50:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2117a06a18478f275c141062f59ee43d9d66a5672a0db356fccc5eb03d4a30c5
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Midera Food Processing, Inc. (MFP) | $1.90B | N/A | N/A | N/A | N/A |
| ADARx Pharmaceuticals, Inc. (ADRX)vs › | $1.89B | N/A | N/A | N/A | N/A |
| Target Hospitality Corp. (TH)vs › | $1.85B | N/A | 0.70 | 0.33 | 0.33 |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.84B | 0.12 | 0.14 | 0.27 | 0.27 |
| Werner Enterprises, Inc. (WERN)vs › | $1.98B | N/A | 2.40 | 1.62 | 1.47 |
| Cimpress plc (CMPR)vs › | $1.80B | N/A | 0.63 | 0.63 | 8.28 |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.01B | N/A | N/A | N/A | N/A |
| Allient Inc. (ALNT)vs › | $2.02B | 10.28 | 8.40 | 4.71 | 3.68 |
| Neutron Holdings, Inc. (LIME)vs › | $1.74B | N/A | N/A | N/A | N/A |
| Preformed Line Products Company (PLPC)vs › | $2.07B | 13.19 | 8.87 | 3.62 | 2.32 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
